The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease

Young‐Suk Lim(Asan Medical Center), W. Ray Kim(Mayo Clinic in Arizona)

Clinics in Liver Disease

October 31, 2008

10.1016/j.cld.2008.07.007

Cited by 314

Related Papers

Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List

|New England Journal of Medicine|2008|1.5k

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease†

|Hepatology|2008|865

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

|Journal of Hepatology|2015|864

Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases

|Hepatology|2021|794

Evidence-Based Incorporation of Serum Sodium Concentration Into MELD

|Gastroenterology|2006|777